Variant report
Variant | esv3386987 |
---|---|
Chromosome Location | chr1:192819539-192821168 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:192818527..192820522-chr1:192821940..192823525,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6428139 | chr1:192819541-192819542 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs531798166 | chr1:192819595-192819596 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548717297 | chr1:192819598-192819599 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs61821630 | chr1:192819615-192819616 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs141792939 | chr1:192819626-192819627 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs372013832 | chr1:192819747-192819748 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540908675 | chr1:192819749-192819750 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs369429379 | chr1:192819754-192819755 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570885565 | chr1:192819761-192819762 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs539838535 | chr1:192819774-192819775 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556734202 | chr1:192819839-192819840 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs373193838 | chr1:192819848-192819849 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs143707928 | chr1:192819886-192819887 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs555507405 | chr1:192819887-192819888 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs187481525 | chr1:192819919-192819920 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs528365486 | chr1:192819953-192819954 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs844529 | chr1:192820049-192820050 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs557628865 | chr1:192820075-192820076 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577260205 | chr1:192820076-192820077 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs542974574 | chr1:192820126-192820127 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs544186124 | chr1:192820135-192820136 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs528927773 | chr1:192820155-192820156 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs842924 | chr1:192820182-192820183 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs562340179 | chr1:192820207-192820208 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs148121244 | chr1:192820247-192820248 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs141832550 | chr1:192820254-192820255 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs571148197 | chr1:192820255-192820256 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567631486 | chr1:192820285-192820286 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs374214447 | chr1:192820289-192820290 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533371195 | chr1:192820300-192820301 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs550150539 | chr1:192820346-192820347 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570182254 | chr1:192820390-192820391 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs150607657 | chr1:192820401-192820402 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs532891711 | chr1:192820483-192820484 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533054702 | chr1:192820502-192820503 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs565916011 | chr1:192820544-192820545 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs371776605 | chr1:192820547-192820548 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs551212682 | chr1:192820555-192820556 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560279617 | chr1:192820566-192820567 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs112703697 | chr1:192820613-192820614 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs534510102 | chr1:192820639-192820640 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs539830320 | chr1:192820663-192820664 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs557641000 | chr1:192820665-192820666 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs527461074 | chr1:192820676-192820677 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs192725398 | chr1:192820721-192820722 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs536670930 | chr1:192820733-192820734 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs560134786 | chr1:192820778-192820779 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs201526414 | chr1:192820839-192820840 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs556503597 | chr1:192820853-192820854 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs57235619 | chr1:192820861-192820862 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 21062444 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:192817000-192819800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
2 | chr1:192817600-192821200 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
3 | chr1:192819200-192820600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
4 | chr1:192819200-192821400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr1:192819800-192820000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr1:192820000-192820400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
7 | chr1:192820200-192820600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr1:192820400-192820800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
9 | chr1:192820400-192820800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr1:192820400-192821000 | Enhancers | Fetal Kidney | kidney |
11 | chr1:192820400-192821000 | Enhancers | HepG2 | liver |
12 | chr1:192820800-192821400 | Enhancers | Brain Germinal Matrix | brain |